![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
21
PharmaCompass offers a list of Alprazolam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alprazolam manufacturer or Alprazolam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alprazolam manufacturer or Alprazolam supplier.
PharmaCompass also assists you with knowing the Alprazolam API Price utilized in the formulation of products. Alprazolam API Price is not always fixed or binding as the Alprazolam Price is obtained through a variety of data sources. The Alprazolam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Niravam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Niravam, including repackagers and relabelers. The FDA regulates Niravam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Niravam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Niravam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Niravam supplier is an individual or a company that provides Niravam active pharmaceutical ingredient (API) or Niravam finished formulations upon request. The Niravam suppliers may include Niravam API manufacturers, exporters, distributors and traders.
click here to find a list of Niravam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Niravam DMF (Drug Master File) is a document detailing the whole manufacturing process of Niravam active pharmaceutical ingredient (API) in detail. Different forms of Niravam DMFs exist exist since differing nations have different regulations, such as Niravam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Niravam DMF submitted to regulatory agencies in the US is known as a USDMF. Niravam USDMF includes data on Niravam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Niravam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Niravam suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Niravam Drug Master File in Japan (Niravam JDMF) empowers Niravam API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Niravam JDMF during the approval evaluation for pharmaceutical products. At the time of Niravam JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Niravam suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Niravam Drug Master File in Korea (Niravam KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Niravam. The MFDS reviews the Niravam KDMF as part of the drug registration process and uses the information provided in the Niravam KDMF to evaluate the safety and efficacy of the drug.
After submitting a Niravam KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Niravam API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Niravam suppliers with KDMF on PharmaCompass.
A Niravam CEP of the European Pharmacopoeia monograph is often referred to as a Niravam Certificate of Suitability (COS). The purpose of a Niravam CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Niravam EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Niravam to their clients by showing that a Niravam CEP has been issued for it. The manufacturer submits a Niravam CEP (COS) as part of the market authorization procedure, and it takes on the role of a Niravam CEP holder for the record. Additionally, the data presented in the Niravam CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Niravam DMF.
A Niravam CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Niravam CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Niravam suppliers with CEP (COS) on PharmaCompass.
A Niravam written confirmation (Niravam WC) is an official document issued by a regulatory agency to a Niravam manufacturer, verifying that the manufacturing facility of a Niravam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Niravam APIs or Niravam finished pharmaceutical products to another nation, regulatory agencies frequently require a Niravam WC (written confirmation) as part of the regulatory process.
click here to find a list of Niravam suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Niravam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Niravam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Niravam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Niravam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Niravam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Niravam suppliers with NDC on PharmaCompass.
Niravam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Niravam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Niravam GMP manufacturer or Niravam GMP API supplier for your needs.
A Niravam CoA (Certificate of Analysis) is a formal document that attests to Niravam's compliance with Niravam specifications and serves as a tool for batch-level quality control.
Niravam CoA mostly includes findings from lab analyses of a specific batch. For each Niravam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Niravam may be tested according to a variety of international standards, such as European Pharmacopoeia (Niravam EP), Niravam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Niravam USP).